Zhaoke Ophthalmology buys back 1.65 million shares in June, equal to 0.30% of share capital

Bulletin Express

Jun 30

Zhaoke Ophthalmology Limited disclosed that it repurchased 1.65 million ordinary shares on the Hong Kong Stock Exchange between 11 June and 30 June 2026. The transactions are pending cancellation, so the company’s issued share count remained unchanged at 548.75 million shares at month-end.

The repurchases were executed in nine tranches at volume-weighted average prices ranging from HKD 2.44 to HKD 2.83 per share. Aggregate consideration is calculated at roughly HKD 4.40 million, implying an overall average cost of about HKD 2.66 per share.

Under the general mandate approved on 15 May 2026, Zhaoke Ophthalmology is authorised to repurchase up to 54.87 million shares. The 1.65 million shares bought to date represent 3.01% of that mandate and approximately 0.30% of the company’s current issued share capital.

A 30-day moratorium on new share issues or treasury-share sales applies until 30 July 2026, in accordance with Hong Kong listing rules.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1107678480"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1107678480\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1107678480?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-30 17:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1107678480","market":"us","top_or_hot":-1,"title":"Zhaoke Ophthalmology buys back 1.65 million shares in June, equal to 0.30% of share capital","media":"Bulletin Express","content":"<p>Zhaoke Ophthalmology Limited disclosed that it repurchased 1.65 million ordinary shares on the Hong Kong Stock Exchange between 11 June and 30 June 2026. The transactions are pending cancellation, so the company’s issued share count remained unchanged at 548.75 million shares at month-end.</p>\n<p>The repurchases were executed in nine tranches at volume-weighted average prices ranging from HKD 2.44 to HKD 2.83 per share. Aggregate consideration is calculated at roughly HKD 4.40 million, implying an overall average cost of about HKD 2.66 per share.</p>\n<p>Under the general mandate approved on 15 May 2026, Zhaoke Ophthalmology is authorised to repurchase up to 54.87 million shares. The 1.65 million shares bought to date represent 3.01% of that mandate and approximately 0.30% of the company’s current issued share capital.</p>\n<p>A 30-day moratorium on new share issues or treasury-share sales applies until 30 July 2026, in accordance with Hong Kong listing rules.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zhaoke Ophthalmology buys back 1.65 million shares in June, equal to 0.30% of share capital</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZhaoke Ophthalmology buys back 1.65 million shares in June, equal to 0.30% of share capital\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-30 17:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zhaoke Ophthalmology Limited disclosed that it repurchased 1.65 million ordinary shares on the Hong Kong Stock Exchange between 11 June and 30 June 2026. The transactions are pending cancellation, so the company’s issued share count remained unchanged at 548.75 million shares at month-end.</p>\n<p>The repurchases were executed in nine tranches at volume-weighted average prices ranging from HKD 2.44 to HKD 2.83 per share. Aggregate consideration is calculated at roughly HKD 4.40 million, implying an overall average cost of about HKD 2.66 per share.</p>\n<p>Under the general mandate approved on 15 May 2026, Zhaoke Ophthalmology is authorised to repurchase up to 54.87 million shares. The 1.65 million shares bought to date represent 3.01% of that mandate and approximately 0.30% of the company’s current issued share capital.</p>\n<p>A 30-day moratorium on new share issues or treasury-share sales applies until 30 July 2026, in accordance with Hong Kong listing rules.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06622","symbol_name":"兆科眼科-B","start_time":0,"source_url":"","article_id":"1107678480","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1107678480","pubTimestamp":1782811405,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zhaoke Ophthalmology Limited disclosed that it repurchased 1.65 million ordinary shares on the Hong Kong Stock Exchange between 11 June and 30 June 2026. The transactions are pending cancellation, so...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06622":"兆科眼科-B"},"translate_title":"兆科眼科6月回购165万股相当于股本0.30%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06622":1},"content_text":"Zhaoke Ophthalmology Limited disclosed that it repurchased 1.65 million ordinary shares on the Hong Kong Stock Exchange between 11 June and 30 June 2026. The transactions are pending cancellation, so the company’s issued share count remained unchanged at 548.75 million shares at month-end.\nThe repurchases were executed in nine tranches at volume-weighted average prices ranging from HKD 2.44 to HKD 2.83 per share. Aggregate consideration is calculated at roughly HKD 4.40 million, implying an overall average cost of about HKD 2.66 per share.\nUnder the general mandate approved on 15 May 2026, Zhaoke Ophthalmology is authorised to repurchase up to 54.87 million shares. The 1.65 million shares bought to date represent 3.01% of that mandate and approximately 0.30% of the company’s current issued share capital.\nA 30-day moratorium on new share issues or treasury-share sales applies until 30 July 2026, in accordance with Hong Kong listing rules.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}